{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T12:39:46Z","timestamp":1771504786461,"version":"3.50.1"},"reference-count":30,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T00:00:00Z","timestamp":1633824000000},"content-version":"unspecified","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Strategic Research in Epidemiology at Karolinska Institutet"},{"name":"the Stockholm County Council ALF project"},{"name":"the Memorial Foundation of Sigurd and Elsa Golje"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2021,9,23]]},"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Pro-inflammatory interleukin 6 (IL6) trans-signalling is associated with increased risk of cardiovascular events (CVEs). Whether this association exists for both sexes is, however, uncertain. Hence, we analysed the risk of CVE associated with IL6 trans-signalling in men and women and investigated if potential interaction between IL6 trans-signalling and sex affects the risk.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In a prospective cohort of 60-year-old men and women without cardiovascular disease (men=2039, women=2193), subjects were followed for 20 years. To assess the IL6 trans-signalling activity, the proportion between the active binary and inactive ternary IL6 complexes, the binary\/ternary ratio (B\/T ratio), was estimated. CVE (myocardial infarction, angina pectoris and ischaemic stroke, n=629) risk was analysed with Cox regression, presented as HRs with 95% CIs. B\/T ratio was dichotomised, with levels &gt;median representing IL6 trans-signalling. Interaction was analysed on the additive scale and expressed as the synergy index (S). Analyses were adjusted for cardiovascular risk factors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>B\/T ratio &gt;median was associated with increased CVE risk in men (HR 1.63; 95% CI 1.32 to 2.01), but not in women (HR 1.21; 95% CI 0.93 to 1.57). There was a significant synergistic interaction (S=1.98; 95% CI 1.15 to 3.42) between the B\/T ratio and male sex, the combination increasing the risk by 88%.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our results suggest differential susceptibility to inflammation mediated by IL6 trans-signalling and subsequent CVE in men and women. The B\/T ratio could be considered as a novel biomarker for cardiovascular risk in men, but not in women.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/openhrt-2021-001694","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T14:54:57Z","timestamp":1633964097000},"page":"e001694","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Interleukin 6 trans-signalling and the risk of future cardiovascular events in men and women"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5673-9950","authenticated-orcid":false,"given":"Yasmin","family":"Miri","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1404-9222","authenticated-orcid":false,"given":"Karin","family":"Leander","sequence":"additional","affiliation":[{"name":"Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Eriksson","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruna","family":"Gigante","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6109-6761","authenticated-orcid":false,"given":"Louise","family":"Ziegler","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,10,11]]},"reference":[{"key":"2025081711023516000_8.2.e001694.1","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2019-315555"},{"key":"2025081711023516000_8.2.e001694.2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000351"},{"key":"2025081711023516000_8.2.e001694.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707914"},{"key":"2025081711023516000_8.2.e001694.4","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2014.127"},{"key":"2025081711023516000_8.2.e001694.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2015.07.004"},{"key":"2025081711023516000_8.2.e001694.6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/cvr\/cvy191","article-title":"Interleukin 6 trans-signalling and risk of future cardiovascular events","volume":"115","author":"Ziegler","year":"2019","journal-title":"Cardiovasc Res"},{"key":"2025081711023516000_8.2.e001694.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.06.077"},{"key":"2025081711023516000_8.2.e001694.8","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.295758"},{"key":"2025081711023516000_8.2.e001694.9","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.4049\/jimmunol.161.11.6347","article-title":"Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses","volume":"161","author":"Muller-Newen","year":"1998","journal-title":"J Immunol"},{"key":"2025081711023516000_8.2.e001694.10","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000148135.08582.97"},{"key":"2025081711023516000_8.2.e001694.11","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-013-0974-0"},{"key":"2025081711023516000_8.2.e001694.12","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.15.1767"},{"key":"2025081711023516000_8.2.e001694.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.04.014"},{"key":"2025081711023516000_8.2.e001694.14","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.003014"},{"key":"2025081711023516000_8.2.e001694.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2015.02.004"},{"key":"2025081711023516000_8.2.e001694.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61931-4"},{"key":"2025081711023516000_8.2.e001694.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60110-X"},{"key":"2025081711023516000_8.2.e001694.18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.21037\/atm.2020.02.27","article-title":"Associations between the IL-6-neutralizing sIL-6R-sgp130 buffer system and coronary artery disease in postmenopausal women","volume":"8","author":"Zhou","year":"2020","journal-title":"Ann Transl Med"},{"key":"2025081711023516000_8.2.e001694.19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.112.972653"},{"key":"2025081711023516000_8.2.e001694.20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/2047487319869694","article-title":"The predictive role of interleukin 6 trans-signalling in middle-aged men and women at low-intermediate risk of cardiovascular events","volume":"27","author":"Ziegler","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"2025081711023516000_8.2.e001694.21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1161\/CIRCRESAHA.118.311098","article-title":"Reassessing the mechanisms of acute coronary syndromes","volume":"124","author":"Libby","year":"2019","journal-title":"Circ Res"},{"key":"2025081711023516000_8.2.e001694.22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1172\/JCI89429","article-title":"Accelerated resolution of inflammation underlies sex differences in inflammatory responses in humans","volume":"127","author":"Rathod","year":"2017","journal-title":"J Clin Invest"},{"key":"2025081711023516000_8.2.e001694.23","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2018-314268"},{"key":"2025081711023516000_8.2.e001694.24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01052","article-title":"The number of X chromosomes influences inflammatory cytokine production following Toll-like receptor stimulation","volume":"10","author":"Lef\u00e8vre","year":"2019","journal-title":"Front Immunol"},{"key":"2025081711023516000_8.2.e001694.25","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0b013e31802e40bd"},{"key":"2025081711023516000_8.2.e001694.26","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.116.307301"},{"key":"2025081711023516000_8.2.e001694.27","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1161\/CIRCULATIONAHA.118.037975","article-title":"Myocardial and systemic inflammation in acute stress-induced (takotsubo) cardiomyopathy","volume":"139","author":"Scally","year":"2019","journal-title":"Circulation"},{"key":"2025081711023516000_8.2.e001694.28","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw171"},{"key":"2025081711023516000_8.2.e001694.29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1912388"},{"key":"2025081711023516000_8.2.e001694.30","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.111.229435"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2021-001694","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T18:03:17Z","timestamp":1755453797000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2021-001694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,10,11]]},"published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10.1136\/openhrt-2021-001694"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2021-001694","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}